Group benefits expects 7-9% adjusted earnings growth in 2026.
MetLife reported a strong Q4 and full year 2025, with record PRT sales and robust growth across segments, particularly in Asia and Latin America. Management raised its group life mortality ratio target and is confident in its 'New Frontier' strategy, reaffirming double-digit EPS growth targets for 2026. The call focused heavily on strategic initiatives, including the Pinebridge acquisition and increased use of reinsurance to support liability growth. Adjusted EPS of $2.58 for Q4 2025, up 24% YoY, and $8.89 for the full year, up 10% YoY.
Buzzberg readGroup benefits expects 7-9% adjusted earnings growth in 2026.MetLife reported a strong Q4 and full year 2025, with record PRT sales and robust growth across segments, particularly in Asia and Latin America. Management raised its group life mortality ratio target and is confident in its 'New Frontier' strategy, reaffirming double-digit EPS growth targets for 2026. The call focused heavily on strategic initiatives, including the Pinebridge acquisition and increased use of reinsurance to support liability growth. Adjusted EPS of $2.58 for Q4 2025, up 24% YoY, and $8.89 for the full year, up 10% YoY.Read full analysisCollapse analysis
MetLife reported a strong Q4 and full year 2025, with record PRT sales and robust growth across segments, particularly in Asia and Latin America. Management raised its group life mortality ratio target and is confident in its 'New Frontier' strategy, reaffirming double-digit EPS growth targets for 2026. The call focused heavily on strategic initiatives, including the Pinebridge acquisition and increased use of reinsurance to support liability growth. Adjusted EPS of $2.58 for Q4 2025, up 24% YoY, and $8.89 for the full year, up 10% YoY.
Record pension risk transfer (PRT) sales of $14 billion in 2025, supported by strategic reinsurance deals with Talcott and Chariot.
Asia and Latin America continue to be key growth drivers, with constant currency sales up 18% and 12% respectively for the full year.
Group life mortality ratio was below target at 83.1% for the full year, prompting a reduction in the 2026 target range to 83-88%.
Revenue$23.814B
reported
EPS$2.58
reported
Gross margin30.53%
reported
Op margin4.69%
reported
What changed this quarter
01
Guidance
Group benefits expects 7-9% adjusted earnings growth in 2026.
Guidance tone
02
Capital Return
MetLife targets $25B cumulative free cash flow by 2029.
Adjusted EPS of $2.58 for Q4 2025, up 24% YoY, and $8.89 for the full year, up 10% YoY.
03
Expenses
Pinebridge acquisition adds 50 bps to direct expense ratio in 2026.
Record pension risk transfer (PRT) sales of $14 billion in 2025, supported by strategic reinsurance deals with Talcott and Chariot.
04
Regulatory
Japan ESR expected at 170-190% for March 2026.
Asia and Latin America continue to be key growth drivers, with constant currency sales up 18% and 12% respectively for the full year.
AI, capex & demand read
AI
Platform & monetization
Management discusses AI as a driver of operational efficiency, citing that AI and other emerging technologies helped lower the direct expense ratio to 11.7% in 2025, ahead of schedule. They also note broader adoption of AI tools across the company to re-engineer processes and enhance speed and accuracy. In group benefits, they acknowledge AI-driven employment actions by clients as a factor in thei
Demand
Bookings & conversion
Management expresses strong confidence in its 'New Frontier' strategy after a strong first year, with momentum expected to continue into 2026 with double-digit EPS growth and a target ROE of 15-17%.
Tone · Confident
Management repeatedly highlights strategic progress, strong results across segments, and reaffirms commitments, conveying confidence in the company's positioning and execution.
Supply-chain alpha
A1
The shift to a new Japan solvency ratio (ESR) is expected to be within a 170-190% target range, and MetLife sees no constraints on dividend capacity from Japan, indicating a stable source of capital.
“As a reminder, this will be the last stat filing in Japan based on the SMR. which will be transitioning to an economic solvency ratio, or ESR. As we have previously disclosed, we expect to report an initial ESR within a range of 170 to 190…”
The non-cash real estate depreciation accounting change will add ~$200 million annually to adjusted earnings, mostly in Corporate & Other, and is a pure financial reporting adjustment that aligns with economic cash flows.
“we have revised our definition of adjusted earnings to exclude the non-cash accounting of real estate depreciation. to align the impact of real estate asset value changes and better reflect the recurring cash flow and returns of the invest…”
Strategic reinsurance transactions (with Talcott and Chariot) reduced earnings from the legacy block in Corporate & Other by ~$130 million for 2026, a key headwind for the segment which guides to a loss of $500-700 million.
“we did some reinsurance transactions in the fourth quarter. So the Talcott transaction we announced, you know, that's about $100 million of lost earnings. We did the Chariot one. So I think close to $30 million of additional lower earnings…”
MetLife views its investment management relationship with Brighthouse as durable, expecting to continue working with the new combined firm; even in a worst-case scenario, the impact on MetLife's EPS would be modest.
“as you mentioned, Bright House, Bright House is a, you know, great relationship for us. We have a long history. We take pride in that. You know, we're excited to have the opportunity to work, you know, with the new combined firm...”
Management acknowledges awareness of Prudential's issues in Japan but deflects, implying no direct impact on MetLife's business; they remain optimistic about their own market position.
“Yeah, look, thanks for the question. We really don't have much to say about it. I mean, we're aware of the situation. We're very optimistic about our position in Japan...”